| Mutation type:Point | Mutation effect:Missense | Nucleotide number:175 | |||
| Genome location:Exon3 | Subdomain:Gla | ||||
| Alpha missense prediction value:0.953 | Alpha missense prediction class:pathogenic | ||||
| No. of patients reported: 2 | |||||
| Patient information: Monoallelic variation (2); Biallelic variation (0) | |||||
| Patient | Sex | Age | Genotype | PC: amidolytic act (%) | PC: clotting act (%) | PC: Ag (%) | PCD type | Clinical presentation (age) | First onset age | Country | Comments | Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | NA | hetero | 71 | NA | 99 | II | Other VTE (52) | 52 | Denmark | NA | PMID: 31821907 |
| 2 | M | NA | hetero | 60 | NA | 53 | I | Other VTE (59) | 59 | Denmark | NA | PMID: 31821907 |
| Mutation type:Point | Mutation effect:Nonsense | Nucleotide number:176 | |||
| Genome location:Exon3 | Subdomain:Gla | ||||
| Alpha missense prediction value:— | Alpha missense prediction class:— | ||||
| No. of patients reported: 1 | |||||
| Patient information: Monoallelic variation (1); Biallelic variation (0) | |||||
| Patient | Sex | Age | Genotype | PC: amidolytic act (%) | PC: clotting act (%) | PC: Ag (%) | PCD type | Clinical presentation (age) | First onset age | Country | Comments | Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | NA | hetero | NA | NA | NA | NA | miscarriage (n=2) | NA | Korea | NA | PMID: 18376272 |
| Mutation type:Point | Mutation effect:Nonsense | Nucleotide number:177 | |||
| Genome location:Exon3 | Subdomain:Gla | ||||
| Alpha missense prediction value:— | Alpha missense prediction class:— | ||||
| No. of patients reported: 2 | |||||
| Patient information: Monoallelic variation (2); Biallelic variation (0) | |||||
| Patient | Sex | Age | Genotype | PC: amidolytic act (%) | PC: clotting act (%) | PC: Ag (%) | PCD type | Clinical presentation (age) | First onset age | Country | Comments | Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NA | NA | hetero | 57 | 40 | 49.5 | I | Other VTE | NA | France | NA | PMID: 32717757 |
| 2 | NA | NA | hetero | 57 | 40 | 49.5 | I | asymptomatic | NA | France | NA | PMID: 32717757 |
| Mutation type:Point; Point | Mutation effect:Nonsense; Missense | Nucleotide number:176; 631 | |||
| Genome location:Exon3; Exon7 | Subdomain:Gla; Activation peptide | ||||
| Alpha missense prediction value:0.1636 | Alpha missense prediction class:benign | ||||
| No. of patients reported: 2 | |||||
| Patient information: Monoallelic variation (0); Biallelic variation (2) | |||||
| Patient | Sex | Age | Genotype | PC: amidolytic act (%) | PC: clotting act (%) | PC: Ag (%) | PCD type | Clinical presentation (age) | First onset age | Country | Comments | Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | NA | c.hetero | NA | 8 | NA | NA | OD | 0-1Y | Korea | BRD (OD); FFP, heparin and tissue plasminogen activator infusion, protein C concentrate, Ceprotin treatment, anticoagulation therapy | PMID: 18376272 |
| 2 | F | NA | c.hetero | NA | <10 | NA | NA | DIC (1D), BD, OD, renal dysgenesis with hypertension | 1D | Korea | ICH (BD), BRD (OD); protein C concentrate, LMWH | PMID: 18376272 |